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TOLERANCE INDUCTION IN B LYMPHOCYTES BY
THYMUS-DEPENDENT ANTIGENS
T Cells May Abrogate B-Cell Tolerance Induction
but Prevent an Antibody Response*
BY JOHN W. SCHRADER
(From The Walter and Eliza Hall Institute ofMedical Research, P. 0., Royal Melbourne Hospital,
Victoria 3050, Australia)
Although recent work has suggested that different mechanisms are responsible for the
state of specific immunological unresponsiveness that can be induced by either thymus-
dependent or thymus-independent antigens (1, 2), it has been shown that B-cell tolerance
to a thymus-dependent antigen can be induced in the absence offunctional T cells both in
vivo and in vitro (1, 3) . Thus, while a complete antibody response to a thymus-dependent
antigen such as fowl gamma globulin (FGG)' requires the presence of specific T cells (4),
there is no obligatory requirement for T cells in the interaction that leads to B-cell
tolerance . In fact there is suggestive evidence that activated T cells may counteract the
tolerogenic process, since B-cell tolerance induction occurs readily in instances where
T-cell activation does not occur because haptens have been presented on nonimmunogenic
synthetic copolymers (5), or on autologous proteins (6-8) or erythrocytes (9) . Additionally,
the physical state of aggregation of the antigen does not seem critical for tolerance
induction by thymus-dependent antigens in the congenitally athymic mouse (1, 3),
suggesting that the reason that aggregates often prevent tolerance induction in euthymic
mice (10, 11) involves the T cell .
This paper approaches two questions raised by the experiments demonstrating
the induction, in vivo (1) or in vitro (3), of B-cell tolerance in spleen cells from
congenitally athymic mice . The first is that since the responsiveness of spleen
cells was studied in both cases in the absence of T cells, there was a theoretical
possibility that IgM antibody-forming cell (AFC) precursors had not been
tolerized, but rather had been switched to IgG AFC precursors that were more
thymus dependent and thus were not activated in the absence of T cells. The
* This is publication no. 2,067 from the Walter and Eliza Hall Institute of Medical Research. This
work was supported by the National Health and Medical Research Council, Canberra, Australia,
National Institutes of Health grant AI-0-3958, and was in part pursuant to contract no. NIH-
NCI-G-7-3889 with the National Cancer Institute ; and by the Volkswagon Foundation grant no. 11
2147.
t Recipient of a National Health and Medical Research Council Medical Postgraduate Scholar-
ship, NHMRC, Canberra, Australia. Present address: The Rockefeller University, New York 10021 .
'Abbreviations used in this paper: AFC, antibody-forming cells; Agg-FGG, aggregated FGG;
De-FGG, deaggregated FGG ; FGG, fowl gamma globulin; HGG, human gamma globulin; LPS,
lipopolysaccharide; PFC, plaque-forming cells; POL, polymerized flagellin .
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second question concerns apparently contradictory proposalsfor theT-cell role in
tolerance induction. While there has been much interest in the role of suppressor
T cells (12, 13) in producing tolerant states, as discussed above, there is
considerable evidence that activated T cells actually counteract tolerance
induction in the B cell .
In this study, partially inbred congenitally athymic nu/nu mice were reconsti-
tuted with near-syngeneic thymocytes either before, during, or after a putative
tolerogenic treatment . Additionally, nu/nu mice were compared with euthymic
mice of a similar genetic background . Results will be presented to demonstrate
firstly, that the B-cell tolerance induced in nu/nu mice by thymus-dependent
antigens persists when these mice are challenged after reconstitution with
thymocytes . Secondly, it will be shown that the presence ofT cells prevents the
induction of B-cell tolerance by nondeaggregated thymus-dependent antigens
and instead priming occurs, both at the level of the T cell and the B cell .
However, coexistent with T-cell and B-cell priming there is also a T-cell-depend-
ent suppressive influence which may mask the priming effect and produce an
overall hyporesponsiveness .
Materials and Methods
Mice .
￿
CBA/H WEHI mice and BALB/c mice of either sex were employed as euthymic strains .
Two lines of partially inbred congenitally athymic (nu/nu) mice were used, the nu/nu gene being on
either a BALB/c or a CBA background . The nu/nu mice used were the progeny of the 4th-6th
backcrosses .
Antigens . FGG was prepared, and ultracentrifuged as previously described (14) . Freshly
deaggregated material was termed "deaggregated FGG" (De-FGG), while deaggregated material
stored in solution at 4-8°C was termed "soluble FGG" . Nonultracentrifuged FGG that was stored
frozen and thawed several times contained many easily visible aggregates and was termed
"aggregated FGG" (Agg-FGG) .
Human gamma globulin (HGG) was obtained from Commonwealth Serum Laboratories,
Parkville, Australia . DNP-HGG was prepared as in the accompanying paper (3) as was DNP-FGG .
The HGG used in some experiments, had been held under alkaline conditions and dialized in parallel
with HGG that was undergoing dinitrophenylation . The average conjugation ratios of the prepara-
tions used ranged from 4 to 16DNPgroups per molecule . DNP-HGGwas ultracentrifuged and stored,
as for FGG .
Lipopolysaccharide (LPS) was obtained from Difco Laboratories, Detroit, Mich . Polymerized
flagellin (POL) and DNP-POL were prepared as described elsewhere (14) .
Tissue Culture .
￿
A modified Marbrook system was used as in the preceding study (3) .
AFCAssay .
￿
Modified hemolytic plaque assays, as described in the preceding study (3), were used
to detect anti-DNP or anti-FGG in suspensions of spleen cells, either freshly prepared or after tissue
culture . Results are expressed as the arithmetic mean of the response of individual spleens or tissue
culture flasks t SEM. Indirect plaque-forming cells were detected using a polyvalent rabbit
antimouse Ig serum at an appropriate dilution (15) .
Treatment of Cell Suspension with Mitomycin C.
￿
Spleen cells were incubated for 30 min at 37°C
with mitomycin C (Sigma Chemical Co ., St. Louis, Mo .) at a concentration of 40 ug/ml, and were
afterwards washed twice through fetal calf serum .
Treatment with Anti-B Serum . This was performed as described elsewhere (16), using an
AKR-anti-C3H-B serum . Preliminary experiments showed that this treatment had no effect on the
ability ofCBA spleen cells to respond in vitro to DNP-POL, a thymus-independent antigen in vitro
(16, 17), indicating that there was no effect on B cells . The same treatment reduced the in vitro
response of CBA or BALB/c spleen cells to sheep erythrocytes by approximately 90% .976
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Results
TheEffect ofPretreatment with Aggregated Hapten-Protein Conjugates on the
Hapten-Specific Response in Either nu/nu or Euthymic Mice . BALB/c type
nu/nu mice were pretreated with 5 mg of aggregated DNP,o-HGG intraperitone-
ally (i .p.) . 2 days later these mice, together with a control group ofnormal nu/nu
mice, were injected intravenously (i.v .) with near-syngeneic BALB/c thymo-
cytes, the addition of thymocytes being designed to allow the expression of any
potential for IgG production (18) . Both groups of mice were challenged withDNP
on a heterologous carrier FGG (DNP-FGG) together with POL as an adjuvant . 2
As shown in Fig . 1, the anti-DNP responses of the mice pretreated with DNP-
HGG were significantly less than the responses of the control nu/nu mice that
had not been pretreated with DNP-HGG, but only reconstituted with thymo-
cytes . Thus pretreatment of the nu/nu mice with aggregated DNP-HGG had in-
duced a hapten-specific B-cell unresponsiveness that was still apparent when
challenge was made in the presence of T cells .
Also shown in Fig . 1 are the results of a second part of the same experiment,
involving euthymic BALB/c mice that were injected with DNP,o-HGG and later
challenged with DNP-FGG plus POL in parallel with the nu/nu mice . In contrast
to the situation in the nu/nu mice, pretreatment with 5 mg DNP-HGG did not
induce unresponsiveness but instead had a marked priming influence on the
DNP-reactive B-cell population . Thus the small anti-DNP response seen when
BALB/c mice were given a single injection of DNP-FGG (100 jug) was increased
strikingly . A similar priming effect on the DNP-reactive B-cell population was
evident when BALB/c mice from the DNP-HGG-pretreated and untreated
control groups were challenged with a different carrier DNP ovalbumin, again
together with POL (data not shown) .
This experiment, together with others of similar design, showed a clear differ-
ence in the effect of nondeaggregated DNP-HGG between nu/nu mice and
euthymic mice, and supported the hypothesis that the presence of T cells in
euthymic mice protected the B cells from tolerance induction, in fact favoring
priming of the B cells . However, similar experiments to be described below,
using FGG rather than a hapten-protein conjugate, were at first sight inconsist-
ent with this framework .
The Paradoxical Effect of the Presence of T Cells on the Induction of
Unresponsiveness 6y FGG . When nu/nu mice were given soluble or aggregated
FGG, and subsequently reconstituted with T cells and challenged with FGG, the
results were consistent with the conclusions reached in the experiments with
hapten-protein conjugates described above . As shown in Fig . 2, the anti-FGG
responses in group B, where nu/nu mice were given 10 mg Agg-FGG and
reconstituted with thymocytes 2 days later, were much lower than the responses
of the control nu/nu mice in group A which had not been pretreated with
Agg-FGG .
However, in contrast to the experiments with aggregated DNP-HGG described
2 Schrader, J.W. 1975. The adjuvant action of thymus-independent antigens such as polymerized
flagellin, lipopolysaccharide, and pneumococcal polysaccharide . Manuscript submitted for publica-
tion .U
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The contrasting effect on the B-cell population of injection of euthymic and athymic
mice with aggregated DNP-HGG. BALB/c mice or BALB/c nu/nu athymic mice were injected
i.p . with 5mg of aggregated DNP,,-HGG . 7days later thenu/nu mice were injected i.v . with 75
x 10 8 BALB/c thymocytes and all mice were injected i.p . with DNP-FGG (100 jug) plusPOL
(10,ug). 6 days later spleens were harvested and anti-DNPAFC assayed . Direct PFC numbers
are represented by solid columns and indirect by open columns, with bars representing the
S.E.M .
above, the presence of T cells during pretreatment with FGG did not seem to
prevent the induction of unresponsiveness . Thus the anti-FGG responses of
euthymic mice treated with Agg-FGG (group E, Fig. 2) were markedly less than
those of nonpretreated mice (group D, Fig. 2) . Furthermore, nu/nu mice that
were treated with 10 mg Agg-FGG i.p . and at the same time were given 75 x 106
thymocytes i.v . (group C, Fig. 2) responded less well to FGG than did mice
receiving thymocytes alone (group A, Fig . 2) .
Clearly thepresence ofT cellsdid not prevent the induction of an unresponsive
state by non-De-FGG . However there was no evidence to indicate whether this
unresponsiveness was due to tolerance of either of the FGG-reactive T or B cells,
or to a separate suppressive influence, and the following experiments were
performed to elucidate this situation .
The Effect of Pretreatment with Agg-FGG on the Subsequent Specific
Responsiveness .of Euthymic Mice . In further experiments designed to clarify
the unexpected tolerogenic effect of non-De-FGG, euthymic mice were injected
with varying doses of Agg-FGG. Fig . 3 shows typical results demonstrating the
effect of such pretreatment of CBA mice on their subsequent responses to FGG
(100,ug) plus POL (10 Ag) . Two facts are apparent : (a) at each dose ofAgg-FGG,
the response of pretreated mice was diminished relative to that of control mice,
the decrease being proportional to the dose of FGG used in pretreatment and (b)978
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The suppressive effect of pretreatment with Agg-FGG in the presence of T cells.
Groups designated A-E from left to right. CBA nu/nu mice were compared with nu/+ litter-
mates in the following groups. A control group of nu/nu mice group A were given 50 x 10,
CBA thymocytes i.v. On day 3 they were immunized with 500l+g FGG (alum precipitated to-
gether with 2 x 108 killed pertussis organisms), given a further injection of 100Pg FGG on day
8, and the spleens were harvested on day 11 . Group B nu/nu mice were pretreated with 10 mg
of Agg-FGG 2 days before reconstitution with thymocytes (day 0) and were challenged as in
group A. Group C nu/nu mice were treated with 10 mg Agg-FGG i.p. at the time of reconstitu-
tion with the thymocytes and were challenged as in group A. Group D were control LM mice
which were challenged with FGG as for group A. LM mice in group E were pretreated with 10
mg Agg-FGG at the same time as group C, andwere challenged with the other groups on day3.
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in all pretreated animals there was pronounced increase in the proportion of
indirect to direct plaque-forming cells (PFC), infact hardly any direct PFC being
detected. These latter results suggested that a "priming" effect was occurring,
despite the overall decrease in the response upon challenge.
The Unresponsiveness Induced by Pretreatment of Euthymic Mice with Large
Doses of Nondeaggregated Proteins is not at the B-Cell Level. Several possible
mechanisms existed to explain the suppression induced when euthymic mice
were pretreated with a protein and challenged with that same molecule . Effects
of the pretreatment regimen on the B-cell population were considered first.
The result of challenge with the hapten on a heterologous carrier (Fig. 1)
suggests that the B-cell population in euthymic mice was being positively
affected or "primed" by pretreatment rather than tolerized. The shiftto a largely
IgG response seen in the small response upon challenge with the homologous100 .000
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The effect on a subsequent response to FGG of pretreatment of euthymic mice with
Agg-FGG. Groups ofCBA mice were injected i.p . with the indicated doses of Agg-FGG . 8 days
later all mice were challenged with 100ugFGG plus 10 kgPOL. Spleens were harvestedon day
13 and anti-FGG AFC assayed . Direct PFC are shown by black columns, indirect by open .
molecule (Fig . 3) was also consistent with such a view . To show that the
suppression caused by pretreatment with FGG was not due to an interference
with the B cell, and furthermore that it could act upon a B-cell population that
was already primed, the following experimental design was employed . BALB/c
were immunized with DNP-POL to provide a population of DNP-reactive
memory B cells andwere later injected i.p . with varying doses ofAgg-FGG . These
mice were challenged after 13 days with DNP-FGG, together with POL as an
adjuvant . Fig . 4 shows that the suppressive effect of pretreatment with large
amounts of carrier protein, applied also to the response of a primed B-cell
population . In this experiment, the hyporesponsiveness was clearly due to an
interference with the activation of the B cells during the challenge, since the
DNP-reactive B cells could not have been rendered tolerant by treatment with
aggregated FGG.
Evidence for a Nonspecific Suppression by Carrier-Reactive Cells.
￿
The two
mechanisms likely to account for the unresponsiveness seen when mice were
treated with nondeaggregated antigen and challenged with the homologous
carrier involved either a lack of carrier-reactive cells, implying that the carrier
reactive cells had been tolerized by the pretreatment, or the T-dependent gen-
eration of a population of carrier-reactive suppressor cells .
Evidence in favor of the latter possibility was obtained in experiments that
indicated that the suppression was nonantigen specific . Fig . 5 shows the results of980
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The suppressive effect of pretreatment with a large dose of aggregated carrier on the
subsequent activation of hapten-primed B cells by the homologous hapten-carrier conjugate .
BALB/c mice primed 6 mo previously withDNP-POL (20 fag) were injected i.p . with 0.1 or 10
mg Agg-FGG. 13 days later both groups of mice received 100Wg DNP-FGGplus 10lug POL i.p .
Spleens were harvested after 6 days and the anti-DNP PFC determined . Direct PFC are
represented by the black columns .
a further part of the experiment shown in Fig . 1 where euthymic (BALB/c) mice
that had been treated with 5 mg of aggregated DNP-HGG were challenged with
DNP-FGG plus POL, in this case together with HGG. It can be seen that the
presence of HGG, the same carrier protein with which the animals had been
pretreated, had a suppressive effect on the antihapten response to the DNP on
the heterologous carrier FGG . Similar experiments (not shown) demonstrated
suppression of the response to FGG in mice that had been pretreated with 5-10
mg of DNP-HGG and challenged with FGG plus POL in the presence of HGG,
and also the reciprocal suppressive effect on the anti-DNP response of giving
FGG together with DNP-HGG or DNP bovine serum albumin, to euthymic
mice pretreated with 10 mg of Agg-FGG . Evidence against the possibility that
carrier-reactive helper cells were absent, was obtained in in vitro experiments to
be presented below.
In Vitro Challenge of Spleen Cells from Euthymic Mice Pretreated with FGG
in Various States ofAggregation. It was previously shown that spleen cellsfrom
donor nu/nu mice that had been pretreated with high (5-10 mg) doses of soluble
thymus-dependent antigens, were specifically unresponsive to in vitro challenge
(1) . It was therefore of interest to explore the effect of similar pretreatment of
euthymic spleen cell donors, in particular seeking evidence for (a) B-cell
tolerance and (b) T-cell-dependent helper activity and/or T-cell-dependent
suppressor activity . CBA mice were injected i.p . or i .v . with FGG in various981
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Nonantigen-specific suppression by carrier-reactive cells in pretreated euthymic mice.
The results of an additional group of mice included in the experiment shown in Fig. 1 are
depicted. Thus a group of BALB/c mice, treated 7 days previously with aggregated
DNP,,HGG (5 mg), was injected with DNP-FGG (100 fag) plus 10 pg POLtogether in this case
with 100 gag HGG (group B) . These mice were killed 6 days later together with the groups
shown in Fig. 1 and the results of the challenge of mice pretreated with DNP-HGG with
DNP-FGG plus POL alone are repeated for the purpose of comparison.
states of aggregation. At varying intervals these mice were sacrificed and then
spleen cells were cultured in vitro. Two forms of in vitro antigenic challenge were
used, FGG (100 kg) in the presence of POL (10,ug), to enable the gauging of the
function of FGG-reactive B cells even though T-cell-function might be ablated,
and FGG (1 Ag) without POL, the latter challenge resulting in an in vitro
anti-FGG response in the present tissue culture system, only in the presence of
primed T cells (e.g. Table VI, below) .
The situation was shown to be complex. Table I showsthe results of one typical
experiment, in which CBA mice were injected i.p. with various doses of FGG,
either freshly deaggregated or in a grossly aggregated form, and challenge was
made either in vivo or in vitro 2 or 9 days later.
2 days after pretreatment of spleen cell donors, in vitro challenge with FGG
plus POL revealed a definite depression of the IgM (direct PFC) response to
FGG (100 Mg) in the presence of POL. However this was accompanied by the
appearance of indirect PFC, indicating IgG production. This was so in the case
of pretreatment with either Agg- or De-FGG. In each case the depression of the
IgM response was greatest with the highest (10 mg) dose used for pretreatment,
and the total (direct plus indirect) PFC response was greatest (and significantly
higher than the total response of control cultures) with the 2-mg pretreatment
regimen. At day 2, in vitro challenge with FGG (1 ttg) gave only small or unde-
tectable responses in all groups. In vivo challenge on day 2 of mice from the same
JOHN W.SCHRADER
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TABLE I
Challenge in In Vitro and In Vivo 2 days after
Pretreatment with FGG
CBA mice were injected i.p . in groups of 10 with either freshly De-FGG or Agg-FGG at the indicated doses . 2 days
later, two mice from each group together with a group of control nontreated mice were sacrificed and the pooled
spleen cells from each group challenged in vitro in four cultures with 100 kg FGG plus 10 Pg POL, plus 0 .1 l+g
DNP-POL (challenge a), and in four cultures with 1 kg FGG alone (challenge b) . After 4 days the cells were
harvested and the anti-FGG direct and indirect AFC response was determined . The anti-DNP AFC response was
also assayed in cultures given challenge (a) . Responses to challenge (b) are shown in parentheses . On day 2, three
mice from each group were challenged in vivo with FGG (100 Wg) plusPOL (5,ug) plus DNP-POL (5 gg) all given in a
single i.p.injection . Spleens were assayed on day 6 .
group used as sources of spleen cell donors for tissue culture, revealed an en-
hancement of the response of cells from donors treated with the lowest (0.2 mg)
dose of both De-FGG and Agg-FGG . Suppression was pronounced only with the
largest pretreatment dose of 10 mg . The responses to the thymus-independent
antigen DNP-POL did not differ significantly between groups either in vitro or in
vivo, except in the case of pretreatment with 10 mg Agg-FGG. The low anti-DNP
response in this case was not typical and was not seen in similar experiments.
In vitro challenge on day 9 (Table II), revealed even clearer evidence of a
priming effect of pretreatment with either De-FGG or Agg-FGG . This was
evident in a shift to IgG production in the response to 100 ug FGGplus POL, and
also in the acquisition of the ability of spleen cells from pretreated mice to
respond to 1 legFGG in vitro . It was of interest that at day 9, although alldoses of
FGG used for pretreatment of donors allowed the spleen cells to respond to 1 NAgof
FGG in vitro, spleen cells from mice pretreated with the 10-mg dose of both
De-FGG and Agg-FGG gave the lowest responses . In vivo challenge on day 9
confirmed the suppressive effects of pretreatment with FGG (data not shown) .
Responses were reduced in all pretreated groups, the greatest effect being seen in
mice pretreated with the 10-mg dose of De-FGG or Agg-FGG .
Evidence for B-Cell Unresponsiveness where CBA Euthymic Spleen Cell
Donors were Pretreated with FGG or DNP-HGG . In some experiments there
was evidence compatible with a degree of B-cell unresponsiveness in that there
was some depression of the in vitro response to FGG plus POL early after
pretreatment of spleen cell donors with an i.v . injection of De-FGG (Table III) .
However, despite the partial reduction of the overall response, there was a
definite shift to IgG production in the response to 100 legFGG given with POL,
which together with the acquisition of the ability to mount a significant response
Pretreat-
In vitro response In vivo response
mentwith Anti-FGG Anti-DNP, Anti-FGG Anti-DNP, FGG
Direct Indirect direct Direct Indirect direct
- mg 437 t 119 (22 t 21) 0(0) 481 t 75 1,0501150 10,500+ 2,300 4,900+71
De-FGG
0 .2 129 t 52(0) 300 t 96(0) 503 t 76 470 t 140 19,070 + 2,500 3,500 t 436
2 107 t 39(212 + 66) 905 t 88(0) 387 +39 200 + 115 8,600 t 4,650 4,400 + 529
10 30 t 16(0) 421 + 37(0) 379 t 29 0 1,070 t 848 4,100 t 1,010
Agg-FGG
0 .2 330 t 104(41 t 21) 120 t 77(0) 676 t 116 150 + 100 15,700 t 4,680 3,233 + 120
2 294 t 103(0) 572 t 167(0) 393 t 88 0 6,467 t 3,590 3,767 + 745
10 126 t 58 (74 t 35) 327 t 60 (0) 756 t 296 88 t 30 433 t 311 1,533 t 390JOHN W.SCHRADER
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TABLE II
Challenge In Vitro 9 days after Pretreatment with FGG
Pretreatment
AFC/culture Anti-FGG Pretreatment
￿
_ Anti-DNP,
Tissue cultures were set up using as spleen cell donors mice pretreated 9 days previously from the
same groups of mice as used in theexperiment shown in TableI. Challenge of thecultures and expres-
sion of results are as in the experiment in Table I.
TABLE III
The Partial Unresponsiveness Evident on In Vitro Challenge,
Early afterPretreatment with De-FGG i.v.
De-FGG (2 mg.i.v.)
Spleen cells from CBA mice injected i.v. 4 days previously with 2 mg of
freshly De-FGG were compared with spleen cells from untreated mice.
Cultures were set up in quadruplicate with the doses of FGG and POL
shown and harvested on day 4. Cultures receiving 100 ug FGG plus 10 ug
POL also were given 0.1 jug DNP-POL, the response to which was not
different in either group.
to 1 ug of FGG given alone, indicated that a priming effect was also occurring.
When cells from FGG-pretreated donors were challenged in vitro with FGG, it
could not be excluded that suppressor T-cell effects, rather than B-cell tolerance,
were involved. Thus a more critical test of the state of the B-cell population was
to challenge with a different carrier from that used in the pretreatment. Table IV
shows the results of such an experiment. Euthymic mice were pretreated with
DNP-HGG, and their spleen cells challenged in vitro with DNP-POL, POL being
Antigens Anti-FGG AFC/culture
FGG POL Direct Indirect
jug ug
1 - 0 0
1 10 150 t 76 0
100 10 880 t 199 0
1 - 66 t 36 0
1 10 51 t 15 191 t 7
100 10 271 t 137 80 t 74
with FGG
Mg
De-FGG
0.2
Direct
898 + 267(56 t 45)
1,905 t266 (751 t 76)
Indirect
0(0)
0(992 t 137)
direct
556 t 181
567 t 79
2 913t214 (373 t 157) 1,102 t 319 (520 t 249) 635 t 37
10 1,197 t80 (462 t 109) 1,785 t 487 (0) 756 t 68
Agg-FGG
0.2 1,407 t 207(394 t 180) 619 t 237(173 t 107) 667 t 171
2 640 t 108(215 t 141) 352 t 146(761 t 367) 719 t 138
10 5411180(95137) 6611313(89183) 5141150984
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TABLE IV
B-Cell Unresponsiveness Induced in Euthymic Mice by
Various Forms of DNP-HGG
Groups of CBA mice were injected i.v. or i.p. as indicated with 5 mg
DNP,-HGG, in phosphate-buffered saline immediately after ultracentrif-
ugation, no. 1 representing the upper 1/3, and no. 3 the lower 1/3 of the
solution. In the case of one group, (a), DNP-HGG in no. 3 was held at 56°C
for 10 min and injected i.p. After 4 days spleen cells pooled from each
group of donors were cultured in quadruplicate with either 50,ug LPS or
0.02 lug DNP-POL plus 10 jig POL, in each case together with 100Fig FGG
as a control antigen . Cultures were harvested on day 3. A third set of
cultures was set up containing LPS and HGG, 1 leg, but the anti-DNP
responses, which did not differ from those to LPS alone, are not shown.
a thymus-independent carrier in this system (17). A second way of investigating
the status of the B-cell population was to test the antigen-independent anti-DNP
response seen when LPS is added to this tissue culture system (19) . A marked
degree of unresponsiveness of DNP-reactive B cells was demonstrated by both
these means (Table IV). This experiment also shows that deaggregated DNP-
HGG was more effective in inducing B-cell unresponsiveness in euthymic mice
when compared with preparations containing aggregates.
Evidence for the Presence of Helper Activity in Spleens of Mice Pretreated
with FGG. The demonstration in the previous experiments that the spleen cells
from FGG-pretreated mice, unlike spleen cells from normal mice, were able to
respond to a small dose of soluble FGG and to readily produce IgG in this in vitro
system, indicated that the donors were equivalent to deliberately immunized
mice (see also Table V) . The appearance of an IgG response in particular
suggested that T-cell as well as B-cell priming was involved (18) . This was
confirmed in in vitro experiments demonstrating that the ability of spleen cells
from mice primed with FGG to respond to FGG, 1 Ag, and to produce IgG, was
sensitive to treatment with anti-B serum plus complement (C) (e .g., Table VI).
Furthermore it was shown that mitomycin C-treated cells from FGG-pretreated
mice enabled spleen cells from normal mice to make IgG (Table V) . Since T cells
recently activated are known to function in vitro after treatmentwith mitomycin
C (20) while antibody production is abolished (data not shown), this confirms the
presence of FGG-activated T cells in the pretreated mice and their positive
influence on IgG production (18) .
Evidence for T-Cell-Mediated SuppressorActivity.
￿
When 3 x 106 spleen cells
from FGG-pretreated mice were added to cultures of spleen cells from mice
Anti-DNP AFC/culture
Donors injected with in response to:
DNP-HGG (5 mg)
DNP-POL LPS
1i .v. 25 f8 80t23
3 i.v. 69 t 23 291 t 23
3 (56°C, 10 min) i.p.'a' 110 t23 544 t96
407 t70 1,290 t90JOHN W.SCHRADER
TABLE V
The Effect of the Addition to Cultures of Normal Cells,
of Mitomycin C-Treated Cells from FGG-Pretreated Mice
CBA mice were injected i.v . with 10mg ofa"deaggregated" preparation of
FGG that had stood at 4-8°C for 15 days . 1 wk later these mice were
sacrificed and their spleen cells cultured in quadruplicate in the presence
ofFGG (100 ug) plus POL (10 ug) (group B), in parallel with cells from
untreated mice (group A) . (*) A third group (C) of cultures each contained
15 x 108 cells from untreated mice plus 3 x 108 mitomycin C-treated cells
from the mice injected with FGG used in group B. For comparison, cells
from mice immunized8 days before with alum-precipitated FGG (500 Ag)
plus pertussis (2 x 10 8 killed organisms) were cultured in parallel (group
D) . Cultures were harvested on day 4, and direct and indirect PFC
assayed.
TABLE VI
T- Cell-Mediated Suppression ofan In Vitro Secondary Response
Spleen cells from CBAmice injected 3wk previously with 100 ug FGG in
CFA were cultured in quadruplicate with FGG (1 jug/ml per 15 x 10 6
viable nucleated cells) . In onegroup cells were treated with anti-B-serum
plusCbefore culture. Also included were groups of cultures containing in
addition 3 x 10 8 spleen cells from CBA mice injected 5days before with
10 mg soluble FGG°, either untreated or incubated with anti-B-serum
and then C. Spleen cells from normal CBA mice, 3 x 10 8/culture were
added to another control group . Cultures were harvested on day 4 .
* Significantly different by Student's t test .
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previously immunized with alum-precipitated FGG and pertussis, there was a
partial suppression of the response to 1 ug of FGG ranging in separate
experiments from 70 to 50% (Table VI) . This suppression was abolished by
treatment of the spleen cells from the FGG-pretreated mice with anti-B serum
and C . Normal spleen cells had no such effect (Table VI) .
Anti-FGG AFC/culture
Group Pretreatment of Donors
Direct Indirect
A - 856 + 256 0
B FGG (10mg i.v .) 0 916 :1: 156
C 761 t 194 430 f 274
D FGG-AP-P (500 ug) 2,409 f 712 1,660 f 218
Cell source
Anti-FGG
Direct
AFC/culture
Indirect
Primed 616 t 290 4,680 t 570
Primed anti-B treated 147 t 119 0
Primed +3 x 108 "tolerant"' 499 f 154 1,905 f 44*
Primed + tolerant (anti-0) 425 t 67 3,900 t 430*
Primed +normal 525 t 72 3,577 t 503986
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Discussion
Firstly, it was shown that the B-cell tolerance induced by thymus-dependent
antigens in congenitally athymic mice was still evident after reconstitution with
T cells . Secondly, these experiments clarify the relationship betweenT cells and
B-cell unresponsiveness . The salient points are firstly that in euthymic mice the
injection of large amounts of nondeaggregated heterologous serum proteins
resulted in a priming effect on the B-cell population (Figs. 1 and 3), an
observation consistent with a large body of work linking aggregation of antigen
with immunogenicity (10, 11) . However, the B-cell-priming effect of large doses
of nondeaggregated antigens in euthymic mice was masked if the mice were
challenged using the same carrier as was used for pretreatment . Even in this case
there was evidence of a priming effect in that there was a shiftto IgGproduction,
despite the overall reduction in the response (Fig . 3) . Thirdly, at least a part of
the effector phase of this T-dependent suppressive effect of carrier-reactive
cells was not antigen specific, although the activation of the suppressor effect
was antigen specific (Fig . 5) . Fourthly, it was shown in an in vitro system that
T-helper activity was generated when CBA mice were pretreated with large
doses of FGG, even when the FGG had been freshly deaggregated, (Tables 11-
IV) . Finally, only early after treatment with De-FGG was there evidence for a
reduced in vitro response by spleen cells from pretreated animals (Table IV) .
Deaggregated DNP-HGG was quite effective in inducing B-cell unresponsive-
ness, while preparations of DNP-HGG containing aggregates were less so (Table
V) .
The interpretation offered for these results is that in the presence ofT cells,
pretreatment ofmice with soluble serum proteins results in a strong tendency for
immunization to occur, in the case of FGG even when FGG is freshly
deaggregated . The activation ofT cells is associated with a halt to the tendency
for B cells to be tolerized as they would be in nu/nu mice, and instead with an
expansion of a population of B cells with the characteristic qualitative property
of memory B cells, namely that they are able to produce IgG antibody in the
presence of helper T cells (18) . The expression of this immunizing effect may be
masked by the generation of a T-cell-dependent suppressive influence as shown
by Basten et al . (21) who demonstrated in an adoptive transfer situation that
spleen cells from mice pretreated with De-FGG possessed both helper and
suppressor T-cell activity .
This interpretation is consistent with the results of Miller et al . (18) whohave previously
reported the difficulty of inducing B-cell tolerance in euthymic mice usingFGG. In the
present study, evidence consistent with B-cell tolerance in euthymic mice was found only
when deaggregated DNP-HGG or De-FGG was used, and in the case of the latter, only
early after pretreatment by i.v . injection . While the possibility that this suppression of
B-cell responsiveness was due to T-cell-mediated suppression was not excluded, it seems
likely that these results reflect a tolerogenic effect on the B-cell population occurring
before T cells have been activated . This is clearer in the case of the tolerance to DNP
induced by DNP-HGG, since it was demonstrable by in vitro challenge with the
heterologous conjugate DNP-POL . Additionally, no suppressor effect has been shown in
preliminary experiments where cells from DNP-HGG-treated mice have been added
together with HGG to cultures of normal spleen cells challenged with DNP-POL .JOHN W.SCHRADER
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It is important to note that both FGG and to a lesser degree DNP-HGG are prone to
aggregation, and this may be relevant in the generation of a suppressor T-cell-governed
tolerance rather than the T- or B-cell deletion type of tolerance that was demonstrated by
Weigle using deaggregated unconjugated HGG (22). Preliminary results suggest that the
presence of substances such as POL or LPS which can prevent the induction of pure B-cell
tolerance in nu/nu mice (1) may, if anything, enhance the development of the T-cell
suppression type of tolerance, again suggesting a parallel between those conditions
normally thought to favor T-cell activation and immunity such as the presence of
aggregates, and those favoring T-cell-dependent suppression. The present experiments
emphasize that while a sufficient dose of antigen can readily tolerize B cells in the absence
of T cells in athymic mice, without any stringent requirements for deaggregation of the
antigen, deaggregation is of much more importance in euthymic mice.
The nonspecificity of the effector phase of the T-cell-dependent suppressor
activity demonstrated in this study is of interest. Gershon and co-workers have
demonstrated the effect of pretreatment of donor animals with antigen on
phytohemagglutinin responsiveness (23) and have linked such a nonspecific
effect with certain types of antigenic competition. It is of interest that, as in the
present study, aggregated antigen produced the nonspecific suppressor effect, in
fact being more effective than soluble antigen. Likewise, a nonspecific effect of
activated T cells may be involved in the immune suppression which can be
associated with allogeneic interactions (24) . Recently, direct evidence has been
reported for a nonspecific suppressor substance that was released from carrier-
primed cells upon contact with the carrier (25) . This suggests that the
suppressive effects of concanavalin A-activated T cells (26, 27) may be a useful
model for studying this one type of T-cell-mediated negative influence. As with
T-cell "help", antigen-bridging or -focusing concepts may be invoked to explain
why responses to homologous carriers are affected more than are those to
different antigens given in the presence of the first carrier . Although suppressor T
cells may be responsible for both antigenic competition effects and the
suppression of a homologous response, other mechanisms may sometimes be
involved. For example, some types of antigenic competition involve antigen-han-
dling mechanisms (28), while there is evidence that some forms of T-cell-depend-
ent suppression are mediated by antigen-specific factors (29, 30).
Summary
Thymus-dependent protein antigens such as fowl gamma globulin (FGG) and
dinitrophenylated-human gamma globulin (DNP-HGG), readily induced toler-
ance of the B cell in the absence of T cells even when these antigens were not
deaggregated. However, when the same doses of antigen were given in the
presence of T cells, the B-cell population was shown to be protected from
tolerance induction, especially when the antigen was not in a deaggregated form .
In this case, there was in fact evidence of a priming effect, manifest in both the
B-cell and T-cell populations. The priming effect on the B-cell population was
demonstrated by an increased response of mice pretreated with DNP-HGG, upon
challenge with DNP conjugated to a heterologous carrier . The priming effect on
the T-cell population was evident in a helper effect demonstrated in vitro.
However, when euthymic mice which had been pretreated with large doses of988
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FGG or DNP-HGG were challenged with the homologous carrier, the results were
different. In this case, there was a profound suppression of the response against
the carrier or the hapten on that carrier. Suppressor activity was also demon-
strated in vitro and was shown to be sensitive to treatment with anti-B-serum
plus complement. Additionally it was shown that the effector phase of the
suppression had a definite nonantigen-specific component. Thus, in pretreated
euthymic mice, provided the homologous carrier was present, the response to a
heterologous carrier was also suppressed.
To account for the observation that nondeaggregated antigens can induce
B-cell tolerance in athymic mice, but B-cell priming and T-cell-mediated
suppression in euthymic mice, it is proposed that B-cell tolerance occurs when
antigen at some critical dose interacts with the B cell in the absence of some
second signal . This second signal is normally provided by the macrophage,
probably with the assistance of the T cell, and its effect is to divert the result of
the interaction of the B cell with antigen towards immunization and away from
tolerance induction. When a large dose of an antigen that tends to form
aggregates is given to an animal possessing functional T cells, both T-dependent
helper and T-dependent suppressor activities are generated, thus accounting for
a situation where the B-cell population is immunized, but B-cell activation is
suppressed in the presence of the original carrier.
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